Publications

Found 599 results
[ Type(Desc)] Year
Conference Paper
Y Li, H Asfour, L Mao, HA Rockman, and N Bursac. "3D Tissue-engineered Model of Pressure-overload Induced Cardiac Fibrosis." In TISSUE ENGINEERING PART A, S64. Vol. 23. 2017.
L Madden, D Koeberl, and N Bursac. "BIOENGINEERED HUMAN MUSCLE FOR PHYSIOLOGICAL STUDIES AND DISEASE MODELING." In MOLECULAR GENETICS AND METABOLISM, 304-305. Vol. 114. 2015.
M Juhas, G Engelmayr, and N Bursac. "Bioengineered Skeletal Muscle With Functional Stem Cell Pool and Capacity for Vascular Integration and Maturation In Vivo." In MOLECULAR THERAPY, S53-S54. Vol. 22. 2014.
N Bursac. "Cardiac Fibroblasts Strongly Affect Cardiac Action Potential Propagation by Paracrine Rather Than Coupling Mechanisms." In CIRCULATION, S635. Vol. 120. 2009.
LC McSpadden, RD Kirkton, and N Bursac. "Cell Therapies for Arrhythmias: Genetically Engineered Coupling Determines the Effect on Anisotropic Cardiac Conduction." In CIRCULATION, S765-S766. Vol. 120. 2009.
A Khodabukus, L Madden, C Jackman, N Prabhu, T Koves, and N Bursac. "Combined Drug and Electrical Stimulation Synergistically Increase Function of Engineered Human Skeletal Muscle." In TISSUE ENGINEERING PART A, S39-S40. Vol. 23. 2017.
L Rao, Y Qian, A Khodabukus, T Ribar, and N Bursac. "Contractile hPSC derived Skeletal Muscle Tissues for Human Disease Modeling." In TISSUE ENGINEERING PART A, S128. Vol. 23. 2017.
D Koeberl, L Case, EC Smith, Y Li, C Walters, C Hornik, B Thurberg, D Bali, N Bursac, and PS Kishnani. "Correction of biochemical abnormalities and gene expression associated with improved muscle function in a phase I/II clinical trial of clenbuterol in Pompe disease patients stably treated with ERT." In Molecular Genetics and Metabolism, S79-S80. Vol. 123. 2018.
A Khodabukus, N Prabhu, and N Bursac. "Development of a Human Tissue-Engineered Model of Duchenne Muscular Dystrophy." In TISSUE ENGINEERING PART A, S115. Vol. 23. 2017.
Y-H Chen, C-H Chou, A Khodabukus, N Bursac, G Truskey, W Kraus, and VB Kraus. "Effects of simulated muscle exercise on chondrocyte gene expression in a 3D-alginate bead model system." In Osteoarthritis and Cartilage, S139-S140. Vol. 26. 2018.
B Liau, N Christoforou, and N Bursac. "Electromechanically Functional Cardiac Tissue Constructs Engineered From Embryonic Stem Cells." In CIRCULATION, S810-S811. Vol. 120. 2009.
N Christoforou, B Liau, N Bursac, and KW Leong. "Engineering an electromechanically functional 3d biosynthetic tissue using embryonic or induced pluripotent stem cells." In CIRCULATION, E735. Vol. 125. 2012.
N Hung, and N Bursac. "Engineering Prokaryotic Sodium Channels for Generation and Control of Mammalian Tissue Excitability." In CIRCULATION. Vol. 134. 2016.
M Juhas, J Wang, J Ye, I Shadrin, and N Bursac. "Engineering Regenerative Skeletal Muscle Tissues." In TISSUE ENGINEERING PART A, S310. Vol. 21. 2015.
C Wang, JA Hennessey, RD Kirkton, C Wang, V Bryson, PB Rosenberg, N Bursac, and GS Pitt. "FGF13 is a Regulator of the Cardiac Voltage-Gated Sodium Channel Nav1.5." In BIOPHYSICAL JOURNAL, 420-421. Vol. 100. 2011.
AB Sklivas, DII Goss, N Bursac, A Khodahukus, T Koves, D Muoio, L Madden, GA Truskey, WE Kraus, and MJ Hubal. "Gene Expression Differences In Three-dimensional Myobundles Compared To Two-dimensional Myocultures." In MEDICINE & SCIENCE IN SPORTS & EXERCISE, 781-782. Vol. 52. 2020.
N Hung, and N Bursac. "Gene Therapy for Heart Disease Using Electrically Active Fibroblasts." In MOLECULAR THERAPY, S144-S145. Vol. 22. 2014.
IY Shadrin, AL Carlson, and N Bursac. "Human Pluripotent Stem Cell-Derived Cardiac Tissue Patch for Use in Cell-Based Cardiac Therapy." In MOLECULAR THERAPY, S206. Vol. 22. 2014.
J Wang, A Khodabukus, M Juhas, N Abutaleb, and N Bursac. "In Vitro Bioengineered Model for Studies of Human Muscle Regeneration." In TISSUE ENGINEERING PART A, S71. Vol. 23. 2017.

Pages